CEFTRIAXONE SODIUM | A065204 | SANDOZ INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Hospira Inc. FDA-2011-P-0059 Hospira Inc. filed this citizen petition pursuant to FDC Act Section 505(j)(2)(C) and 21 CFR 314.93 requesting that FDA designate Sandoz's Ceftriaxone for Injection 1g and 2g in ADD-Vantage Vial (ANDA 065204) as an additional Reference Listed Drug so that generic applicants may submit ANDAs citing t | 505(q) | 2011-01-27 | Granted | Hospira Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.